Health News

Home Run for Pediatric Cancer Drug
An early study looking at a treatment for cancers involving a certain gene mutation had better results than expected, with findings showing that no traces of cancer are detectable in some of the patients in the drug trial.
Fish Show How Cancer Grows
Genetic studies in a laboratory favorite, zebrafish , have shown that a pediatric cancer has more than one type of cell involved. Some cancer cells specialize in metastasis while others are content to stay where they are.
Kidney Drug Works for Other Cancers
Despite being tailor-made for specific targets, some of the newer cancer drugs are useful in other types of cancer. A new kidney cancer drug has shown to be effective in metastatic cancer.
Chemotherapy? Just For The Tumor, Please
Chemotherapy is effective for cancers that have spread out, but that's a double edged sword. You don't want the drugs harming cells in places without cancer, so it would be nice if you could direct it a little.
The Science Behind Sarcomas
Deep tissue cancers, also known as sarcomas, are not as common as carcinomas and consequently less basic research has been resolved on the causes and medical treatments investigated on sarcomas. A series of laboratory molecular experiments resulted in narrowing down more than 2,000 possible targets for pharmaceutical treatment of sarcomas. Scientists conclude that these cancers born from fat or muscle are most likely to share 39 common proteins. Ask your oncologist about clinical trials available to you. Identifying which molecular targets are the most common in sarcomas is ...
Votrient Treating Advanced Soft-Tissue Sarcoma
It usually starts as a lump under the skin that doesn't hurt or cause any real symptoms. Soft-tissue sarcoma usually shows up on an arm or leg, and it's very treatable if caught early.
Votrient for Advanced Soft Tissue Sarcoma
The U.S. Food and Drug Administration approved Votrient ( pazopanib ) to treat patients with advanced soft tissue sarcoma who have previously received chemotherapy.
Head and Neck Cancer Protein Identified
Different kinds of cancer have different characteristics on a cellular level, and these unique proteins can be used to monitor the cancer's progress or serve as a target for the pharmaceutical version of a smart bomb.
Monitoring Cancer Treatment Faster
Meeting the demand for cancer treatment results, an imaging technology has been adapted to monitor the success of chemotherapy in patients with cancer of the head and neck.
Eradicating Some Advanced Head and Neck Cancers
Every type of cancer has different characteristics, and routine studies constantly attempt to find the best treatment for a given group of patients. A recent study shows evidence that combination therapy may be best for some cancer patients.